Tripta Bansal
Impact in
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 9
- Drug Transport and Resistance Mechanisms 8
-
- Cancer therapeutics and mechanisms 5
- Co-authors
- Sushama Talegaonkar (9 shared papers)Manu Jaggi (7 shared papers)Roop K. Khar (4 shared papers)Roop Khar (2 shared papers)Roop K. Khar (2 shared papers)Gautam Mishra (2 shared papers)Naseem Akhtar (1 shared paper)Anshumali Awasthi (2 shared papers)
- Journals
- Journal of Chromatography B (2 papers)Critical Reviews in Therapeutic Drug Carrier Systems (1 paper)Life Sciences (1 paper)European Journal of Pharmaceutical Sciences (1 paper)Journal of Pharmacy & Pharmaceutical Sciences (1 paper)
- Partner nations
- India
In The Last Decade
Tripta Bansal
12 papers receiving 697 citations
Peers
Comparison fields: 5 of 83
- Pharmaceutical Science 176
- Pharmacology 125
- Oncology 334
- Biomaterials 124
- Pharmacology 93
Countries citing papers authored by Tripta Bansal
This map shows the geographic impact of Tripta Bansal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tripta Bansal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tripta Bansal more than expected).
Fields of papers citing papers by Tripta Bansal
This network shows the impact of papers produced by Tripta Bansal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tripta Bansal. The network helps show where Tripta Bansal may publish in the future.
Co-authors
The 16 scholars most cited alongside Tripta Bansal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 197 | |
| 2 | 2009 | 133 | |
| 3 | 2008 | 120 | |
| 4 | 2008 | 61 | |
| 5 | 2008 | 48 | |
| 6 | 2007 | 42 | |
| 7 | 2008 | 37 | |
| 8 | 2009 | 37 | |
| 9 | 2008 | 22 | |
| 10 | Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux. | 2005 | 17 |
| 11 | 2004 | 13 | |
| 12 | 2009 | 1 |
About Tripta Bansal
Tripta Bansal is a scholar working on Oncology, Molecular Biology, Pharmaceutical Science, Infectious Diseases and Pharmacology, having authored 12 papers that have together received 728 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Cancer therapeutics and mechanisms (5 papers), Drug Solubulity and Delivery Systems (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), HIV/AIDS drug development and treatment (2 papers), Microbial Metabolites in Food Biotechnology (1 paper), HIV Research and Treatment (1 paper) and Probiotics and Fermented Foods (1 paper). The work is most often cited by research in Pharmaceutical Science (176 citations), Pharmacology (125 citations), Oncology (334 citations), Biomaterials (124 citations) and Pharmacology (93 citations). Tripta Bansal has collaborated with scholars based in India. Frequent co-authors include Sushama Talegaonkar, Manu Jaggi, Roop K. Khar, Roop Khar, Roop K. Khar, Gautam Mishra, Naseem Akhtar, Anshumali Awasthi, Gulam Mustafa and Zeenat Khan. Their work appears in journals such as Journal of Chromatography B, Critical Reviews in Therapeutic Drug Carrier Systems, Life Sciences, European Journal of Pharmaceutical Sciences and Journal of Pharmacy & Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.